Veterinary Medicines Information website

Artuvetrin-Therapie Mijten/Insecten suspensie voor injectie voor honden

Authorised
  • DERMATOPHAGOIDES FARINAE EXTRACT
  • Ctenocephalides spp. extract
  • LEPIDOGLYPHUS DESTRUCTOR EXTRACT
  • Musca domestica extract
  • Aedes communis extract
  • DERMATOPHAGOIDES PTERONYSSINUS EXTRACT
  • ACARUS SIRO EXTRACT
  • TYROPHAGUS PUTRESCENTIAE EXTRACT
Download as PDF

Product identification

Medicine name:
Artuvetrin-Therapie Mijten/Insecten suspensie voor injectie voor honden
Active substance:
  • DERMATOPHAGOIDES FARINAE EXTRACT
  • Ctenocephalides spp. extract
  • LEPIDOGLYPHUS DESTRUCTOR EXTRACT
  • Musca domestica extract
  • Aedes communis extract
  • DERMATOPHAGOIDES PTERONYSSINUS EXTRACT
  • ACARUS SIRO EXTRACT
  • TYROPHAGUS PUTRESCENTIAE EXTRACT
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • DERMATOPHAGOIDES FARINAE EXTRACT
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • Ctenocephalides spp. extract
    10.00
    noon unit
    /
    1.00
    millilitre(s)
  • LEPIDOGLYPHUS DESTRUCTOR EXTRACT
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • Musca domestica extract
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • Aedes communis extract
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • DERMATOPHAGOIDES PTERONYSSINUS EXTRACT
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • ACARUS SIRO EXTRACT
    100.00
    noon unit
    /
    1.00
    millilitre(s)
  • TYROPHAGUS PUTRESCENTIAE EXTRACT
    100.00
    noon unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV01AA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Nextmune B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Nextmune B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 7640
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 3/06/2026
Download